Global Deuterated Drugs Market Insights, Forecast to 2029
This report presents an overview of global market for Deuterated Drugs market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Deuterated Drugs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Deuterated Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Deuterated Drugs revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Deuterated Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Deuterated Drugs revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Teva, Suzhou Zelgen Biopharmaceuticals, Concert Pharmaceuticals, Vertex Pharmaceuticals, Hinova Pharma, Otsuka Pharmaceutical (Avanir) and Poxel SA (DeuteRx), etc.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Deuterated Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Deuterated Drugs companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Deuterated Drugs revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
This report researches the key producers of Deuterated Drugs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Deuterated Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Deuterated Drugs revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Deuterated Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Deuterated Drugs revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Teva, Suzhou Zelgen Biopharmaceuticals, Concert Pharmaceuticals, Vertex Pharmaceuticals, Hinova Pharma, Otsuka Pharmaceutical (Avanir) and Poxel SA (DeuteRx), etc.
By Company
- Teva
- Suzhou Zelgen Biopharmaceuticals
- Concert Pharmaceuticals
- Vertex Pharmaceuticals
- Hinova Pharma
- Otsuka Pharmaceutical (Avanir)
- Poxel SA (DeuteRx)
- Austedo
- Zepsun
- Others
- Huntington'S Disease (HD)
- Tardive Dyskinesia (TD)
- Cancer
- Others
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East, Africa, and Latin America
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Deuterated Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Deuterated Drugs companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Deuterated Drugs revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Deuterated Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Austedo
1.2.3 Zepsun
1.2.4 Others
1.3 Market by Application
1.3.1 Global Deuterated Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Huntington'S Disease (HD)
1.3.3 Tardive Dyskinesia (TD)
1.3.4 Cancer
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Deuterated Drugs Market Perspective (2018-2029)
2.2 Global Deuterated Drugs Growth Trends by Region
2.2.1 Deuterated Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Deuterated Drugs Historic Market Size by Region (2018-2023)
2.2.3 Deuterated Drugs Forecasted Market Size by Region (2024-2029)
2.3 Deuterated Drugs Market Dynamics
2.3.1 Deuterated Drugs Industry Trends
2.3.2 Deuterated Drugs Market Drivers
2.3.3 Deuterated Drugs Market Challenges
2.3.4 Deuterated Drugs Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Revenue Deuterated Drugs by Players
3.1.1 Global Deuterated Drugs Revenue by Players (2018-2023)
3.1.2 Global Deuterated Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Deuterated Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Deuterated Drugs, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Deuterated Drugs Market Concentration Ratio
3.4.1 Global Deuterated Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Deuterated Drugs Revenue in 2022
3.5 Global Key Players of Deuterated Drugs Head office and Area Served
3.6 Global Key Players of Deuterated Drugs, Product and Application
3.7 Global Key Players of Deuterated Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 DEUTERATED DRUGS BREAKDOWN DATA BY TYPE
4.1 Global Deuterated Drugs Historic Market Size by Type (2018-2023)
4.2 Global Deuterated Drugs Forecasted Market Size by Type (2024-2029)
5 DEUTERATED DRUGS BREAKDOWN DATA BY APPLICATION
5.1 Global Deuterated Drugs Historic Market Size by Application (2018-2023)
5.2 Global Deuterated Drugs Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Deuterated Drugs Market Size (2018-2029)
6.2 North America Deuterated Drugs Market Size by Type
6.2.1 North America Deuterated Drugs Market Size by Type (2018-2023)
6.2.2 North America Deuterated Drugs Market Size by Type (2024-2029)
6.2.3 North America Deuterated Drugs Market Share by Type (2018-2029)
6.3 North America Deuterated Drugs Market Size by Application
6.3.1 North America Deuterated Drugs Market Size by Application (2018-2023)
6.3.2 North America Deuterated Drugs Market Size by Application (2024-2029)
6.3.3 North America Deuterated Drugs Market Share by Application (2018-2029)
6.4 North America Deuterated Drugs Market Size by Country
6.4.1 North America Deuterated Drugs Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Deuterated Drugs Market Size by Country (2018-2023)
6.4.3 North America Deuterated Drugs Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 EUROPE
7.1 Europe Deuterated Drugs Market Size (2018-2029)
7.2 Europe Deuterated Drugs Market Size by Type
7.2.1 Europe Deuterated Drugs Market Size by Type (2018-2023)
7.2.2 Europe Deuterated Drugs Market Size by Type (2024-2029)
7.2.3 Europe Deuterated Drugs Market Share by Type (2018-2029)
7.3 Europe Deuterated Drugs Market Size by Application
7.3.1 Europe Deuterated Drugs Market Size by Application (2018-2023)
7.3.2 Europe Deuterated Drugs Market Size by Application (2024-2029)
7.3.3 Europe Deuterated Drugs Market Share by Application (2018-2029)
7.4 Europe Deuterated Drugs Market Size by Country
7.4.1 Europe Deuterated Drugs Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Deuterated Drugs Market Size by Country (2018-2023)
7.4.3 Europe Deuterated Drugs Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 CHINA
8.1 China Deuterated Drugs Market Size (2018-2029)
8.2 China Deuterated Drugs Market Size by Type
8.2.1 China Deuterated Drugs Market Size by Type (2018-2023)
8.2.2 China Deuterated Drugs Market Size by Type (2024-2029)
8.2.3 China Deuterated Drugs Market Share by Type (2018-2029)
8.3 China Deuterated Drugs Market Size by Application
8.3.1 China Deuterated Drugs Market Size by Application (2018-2023)
8.3.2 China Deuterated Drugs Market Size by Application (2024-2029)
8.3.3 China Deuterated Drugs Market Share by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Deuterated Drugs Market Size (2018-2029)
9.2 Asia Deuterated Drugs Market Size by Type
9.2.1 Asia Deuterated Drugs Market Size by Type (2018-2023)
9.2.2 Asia Deuterated Drugs Market Size by Type (2024-2029)
9.2.3 Asia Deuterated Drugs Market Share by Type (2018-2029)
9.3 Asia Deuterated Drugs Market Size by Application
9.3.1 Asia Deuterated Drugs Market Size by Application (2018-2023)
9.3.2 Asia Deuterated Drugs Market Size by Application (2024-2029)
9.3.3 Asia Deuterated Drugs Market Share by Application (2018-2029)
9.4 Asia Deuterated Drugs Market Size by Region
9.4.1 Asia Deuterated Drugs Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Deuterated Drugs Market Size by Region (2018-2023)
9.4.3 Asia Deuterated Drugs Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 MIDDLE EAST, AFRICA, AND LATIN AMERICA
10.1 Middle East, Africa, and Latin America Deuterated Drugs Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Deuterated Drugs Market Size by Type
10.2.1 Middle East, Africa, and Latin America Deuterated Drugs Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Deuterated Drugs Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Deuterated Drugs Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Deuterated Drugs Market Size by Application
10.3.1 Middle East, Africa, and Latin America Deuterated Drugs Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Deuterated Drugs Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Deuterated Drugs Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Deuterated Drugs Market Size by Country
10.4.1 Middle East, Africa, and Latin America Deuterated Drugs Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Deuterated Drugs Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Deuterated Drugs Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 KEY PLAYERS PROFILES
11.1 Teva
11.1.1 Teva Company Details
11.1.2 Teva Business Overview
11.1.3 Teva Deuterated Drugs Introduction
11.1.4 Teva Revenue in Deuterated Drugs Business (2018-2023)
11.1.5 Teva Recent Developments
11.2 Suzhou Zelgen Biopharmaceuticals
11.2.1 Suzhou Zelgen Biopharmaceuticals Company Details
11.2.2 Suzhou Zelgen Biopharmaceuticals Business Overview
11.2.3 Suzhou Zelgen Biopharmaceuticals Deuterated Drugs Introduction
11.2.4 Suzhou Zelgen Biopharmaceuticals Revenue in Deuterated Drugs Business (2018-2023)
11.2.5 Suzhou Zelgen Biopharmaceuticals Recent Developments
11.3 Concert Pharmaceuticals
11.3.1 Concert Pharmaceuticals Company Details
11.3.2 Concert Pharmaceuticals Business Overview
11.3.3 Concert Pharmaceuticals Deuterated Drugs Introduction
11.3.4 Concert Pharmaceuticals Revenue in Deuterated Drugs Business (2018-2023)
11.3.5 Concert Pharmaceuticals Recent Developments
11.4 Vertex Pharmaceuticals
11.4.1 Vertex Pharmaceuticals Company Details
11.4.2 Vertex Pharmaceuticals Business Overview
11.4.3 Vertex Pharmaceuticals Deuterated Drugs Introduction
11.4.4 Vertex Pharmaceuticals Revenue in Deuterated Drugs Business (2018-2023)
11.4.5 Vertex Pharmaceuticals Recent Developments
11.5 Hinova Pharma
11.5.1 Hinova Pharma Company Details
11.5.2 Hinova Pharma Business Overview
11.5.3 Hinova Pharma Deuterated Drugs Introduction
11.5.4 Hinova Pharma Revenue in Deuterated Drugs Business (2018-2023)
11.5.5 Hinova Pharma Recent Developments
11.6 Otsuka Pharmaceutical (Avanir)
11.6.1 Otsuka Pharmaceutical (Avanir) Company Details
11.6.2 Otsuka Pharmaceutical (Avanir) Business Overview
11.6.3 Otsuka Pharmaceutical (Avanir) Deuterated Drugs Introduction
11.6.4 Otsuka Pharmaceutical (Avanir) Revenue in Deuterated Drugs Business (2018-2023)
11.6.5 Otsuka Pharmaceutical (Avanir) Recent Developments
11.7 Poxel SA (DeuteRx)
11.7.1 Poxel SA (DeuteRx) Company Details
11.7.2 Poxel SA (DeuteRx) Business Overview
11.7.3 Poxel SA (DeuteRx) Deuterated Drugs Introduction
11.7.4 Poxel SA (DeuteRx) Revenue in Deuterated Drugs Business (2018-2023)
11.7.5 Poxel SA (DeuteRx) Recent Developments
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Deuterated Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Austedo
1.2.3 Zepsun
1.2.4 Others
1.3 Market by Application
1.3.1 Global Deuterated Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Huntington'S Disease (HD)
1.3.3 Tardive Dyskinesia (TD)
1.3.4 Cancer
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Deuterated Drugs Market Perspective (2018-2029)
2.2 Global Deuterated Drugs Growth Trends by Region
2.2.1 Deuterated Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Deuterated Drugs Historic Market Size by Region (2018-2023)
2.2.3 Deuterated Drugs Forecasted Market Size by Region (2024-2029)
2.3 Deuterated Drugs Market Dynamics
2.3.1 Deuterated Drugs Industry Trends
2.3.2 Deuterated Drugs Market Drivers
2.3.3 Deuterated Drugs Market Challenges
2.3.4 Deuterated Drugs Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Revenue Deuterated Drugs by Players
3.1.1 Global Deuterated Drugs Revenue by Players (2018-2023)
3.1.2 Global Deuterated Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Deuterated Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Deuterated Drugs, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Deuterated Drugs Market Concentration Ratio
3.4.1 Global Deuterated Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Deuterated Drugs Revenue in 2022
3.5 Global Key Players of Deuterated Drugs Head office and Area Served
3.6 Global Key Players of Deuterated Drugs, Product and Application
3.7 Global Key Players of Deuterated Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 DEUTERATED DRUGS BREAKDOWN DATA BY TYPE
4.1 Global Deuterated Drugs Historic Market Size by Type (2018-2023)
4.2 Global Deuterated Drugs Forecasted Market Size by Type (2024-2029)
5 DEUTERATED DRUGS BREAKDOWN DATA BY APPLICATION
5.1 Global Deuterated Drugs Historic Market Size by Application (2018-2023)
5.2 Global Deuterated Drugs Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Deuterated Drugs Market Size (2018-2029)
6.2 North America Deuterated Drugs Market Size by Type
6.2.1 North America Deuterated Drugs Market Size by Type (2018-2023)
6.2.2 North America Deuterated Drugs Market Size by Type (2024-2029)
6.2.3 North America Deuterated Drugs Market Share by Type (2018-2029)
6.3 North America Deuterated Drugs Market Size by Application
6.3.1 North America Deuterated Drugs Market Size by Application (2018-2023)
6.3.2 North America Deuterated Drugs Market Size by Application (2024-2029)
6.3.3 North America Deuterated Drugs Market Share by Application (2018-2029)
6.4 North America Deuterated Drugs Market Size by Country
6.4.1 North America Deuterated Drugs Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Deuterated Drugs Market Size by Country (2018-2023)
6.4.3 North America Deuterated Drugs Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 EUROPE
7.1 Europe Deuterated Drugs Market Size (2018-2029)
7.2 Europe Deuterated Drugs Market Size by Type
7.2.1 Europe Deuterated Drugs Market Size by Type (2018-2023)
7.2.2 Europe Deuterated Drugs Market Size by Type (2024-2029)
7.2.3 Europe Deuterated Drugs Market Share by Type (2018-2029)
7.3 Europe Deuterated Drugs Market Size by Application
7.3.1 Europe Deuterated Drugs Market Size by Application (2018-2023)
7.3.2 Europe Deuterated Drugs Market Size by Application (2024-2029)
7.3.3 Europe Deuterated Drugs Market Share by Application (2018-2029)
7.4 Europe Deuterated Drugs Market Size by Country
7.4.1 Europe Deuterated Drugs Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Deuterated Drugs Market Size by Country (2018-2023)
7.4.3 Europe Deuterated Drugs Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 CHINA
8.1 China Deuterated Drugs Market Size (2018-2029)
8.2 China Deuterated Drugs Market Size by Type
8.2.1 China Deuterated Drugs Market Size by Type (2018-2023)
8.2.2 China Deuterated Drugs Market Size by Type (2024-2029)
8.2.3 China Deuterated Drugs Market Share by Type (2018-2029)
8.3 China Deuterated Drugs Market Size by Application
8.3.1 China Deuterated Drugs Market Size by Application (2018-2023)
8.3.2 China Deuterated Drugs Market Size by Application (2024-2029)
8.3.3 China Deuterated Drugs Market Share by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Deuterated Drugs Market Size (2018-2029)
9.2 Asia Deuterated Drugs Market Size by Type
9.2.1 Asia Deuterated Drugs Market Size by Type (2018-2023)
9.2.2 Asia Deuterated Drugs Market Size by Type (2024-2029)
9.2.3 Asia Deuterated Drugs Market Share by Type (2018-2029)
9.3 Asia Deuterated Drugs Market Size by Application
9.3.1 Asia Deuterated Drugs Market Size by Application (2018-2023)
9.3.2 Asia Deuterated Drugs Market Size by Application (2024-2029)
9.3.3 Asia Deuterated Drugs Market Share by Application (2018-2029)
9.4 Asia Deuterated Drugs Market Size by Region
9.4.1 Asia Deuterated Drugs Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Deuterated Drugs Market Size by Region (2018-2023)
9.4.3 Asia Deuterated Drugs Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 MIDDLE EAST, AFRICA, AND LATIN AMERICA
10.1 Middle East, Africa, and Latin America Deuterated Drugs Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Deuterated Drugs Market Size by Type
10.2.1 Middle East, Africa, and Latin America Deuterated Drugs Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Deuterated Drugs Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Deuterated Drugs Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Deuterated Drugs Market Size by Application
10.3.1 Middle East, Africa, and Latin America Deuterated Drugs Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Deuterated Drugs Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Deuterated Drugs Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Deuterated Drugs Market Size by Country
10.4.1 Middle East, Africa, and Latin America Deuterated Drugs Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Deuterated Drugs Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Deuterated Drugs Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 KEY PLAYERS PROFILES
11.1 Teva
11.1.1 Teva Company Details
11.1.2 Teva Business Overview
11.1.3 Teva Deuterated Drugs Introduction
11.1.4 Teva Revenue in Deuterated Drugs Business (2018-2023)
11.1.5 Teva Recent Developments
11.2 Suzhou Zelgen Biopharmaceuticals
11.2.1 Suzhou Zelgen Biopharmaceuticals Company Details
11.2.2 Suzhou Zelgen Biopharmaceuticals Business Overview
11.2.3 Suzhou Zelgen Biopharmaceuticals Deuterated Drugs Introduction
11.2.4 Suzhou Zelgen Biopharmaceuticals Revenue in Deuterated Drugs Business (2018-2023)
11.2.5 Suzhou Zelgen Biopharmaceuticals Recent Developments
11.3 Concert Pharmaceuticals
11.3.1 Concert Pharmaceuticals Company Details
11.3.2 Concert Pharmaceuticals Business Overview
11.3.3 Concert Pharmaceuticals Deuterated Drugs Introduction
11.3.4 Concert Pharmaceuticals Revenue in Deuterated Drugs Business (2018-2023)
11.3.5 Concert Pharmaceuticals Recent Developments
11.4 Vertex Pharmaceuticals
11.4.1 Vertex Pharmaceuticals Company Details
11.4.2 Vertex Pharmaceuticals Business Overview
11.4.3 Vertex Pharmaceuticals Deuterated Drugs Introduction
11.4.4 Vertex Pharmaceuticals Revenue in Deuterated Drugs Business (2018-2023)
11.4.5 Vertex Pharmaceuticals Recent Developments
11.5 Hinova Pharma
11.5.1 Hinova Pharma Company Details
11.5.2 Hinova Pharma Business Overview
11.5.3 Hinova Pharma Deuterated Drugs Introduction
11.5.4 Hinova Pharma Revenue in Deuterated Drugs Business (2018-2023)
11.5.5 Hinova Pharma Recent Developments
11.6 Otsuka Pharmaceutical (Avanir)
11.6.1 Otsuka Pharmaceutical (Avanir) Company Details
11.6.2 Otsuka Pharmaceutical (Avanir) Business Overview
11.6.3 Otsuka Pharmaceutical (Avanir) Deuterated Drugs Introduction
11.6.4 Otsuka Pharmaceutical (Avanir) Revenue in Deuterated Drugs Business (2018-2023)
11.6.5 Otsuka Pharmaceutical (Avanir) Recent Developments
11.7 Poxel SA (DeuteRx)
11.7.1 Poxel SA (DeuteRx) Company Details
11.7.2 Poxel SA (DeuteRx) Business Overview
11.7.3 Poxel SA (DeuteRx) Deuterated Drugs Introduction
11.7.4 Poxel SA (DeuteRx) Revenue in Deuterated Drugs Business (2018-2023)
11.7.5 Poxel SA (DeuteRx) Recent Developments
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Deuterated Drugs Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Austedo
Table 3. Key Players of Zepsun
Table 4. Key Players of Others
Table 5. Global Deuterated Drugs Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 6. Global Deuterated Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Deuterated Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Deuterated Drugs Market Share by Region (2018-2023)
Table 9. Global Deuterated Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Deuterated Drugs Market Share by Region (2024-2029)
Table 11. Deuterated Drugs Market Trends
Table 12. Deuterated Drugs Market Drivers
Table 13. Deuterated Drugs Market Challenges
Table 14. Deuterated Drugs Market Restraints
Table 15. Global Deuterated Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Deuterated Drugs Revenue Share by Players (2018-2023)
Table 17. Global Top Deuterated Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Deuterated Drugs as of 2022)
Table 18. Global Deuterated Drugs Industry Ranking 2021 VS 2022 VS 2023
Table 19. Global 5 Largest Players Market Share by Deuterated Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 20. Global Key Players of Deuterated Drugs, Headquarters and Area Served
Table 21. Global Key Players of Deuterated Drugs, Product and Application
Table 22. Global Key Players of Deuterated Drugs, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Deuterated Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Deuterated Drugs Revenue Market Share by Type (2018-2023)
Table 26. Global Deuterated Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Deuterated Drugs Revenue Market Share by Type (2024-2029)
Table 28. Global Deuterated Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Deuterated Drugs Revenue Share by Application (2018-2023)
Table 30. Global Deuterated Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Deuterated Drugs Revenue Share by Application (2024-2029)
Table 32. North America Deuterated Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 33. North America Deuterated Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 34. North America Deuterated Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 35. North America Deuterated Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 36. North America Deuterated Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. North America Deuterated Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Deuterated Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 39. Europe Deuterated Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 40. Europe Deuterated Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 41. Europe Deuterated Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 42. Europe Deuterated Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 43. Europe Deuterated Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Europe Deuterated Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 45. Europe Deuterated Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 46. China Deuterated Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 47. China Deuterated Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 48. China Deuterated Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 49. China Deuterated Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 50. Asia Deuterated Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 51. Asia Deuterated Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 52. Asia Deuterated Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 53. Asia Deuterated Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 54. Asia Deuterated Drugs Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 55. Asia Deuterated Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 56. Asia Deuterated Drugs Market Size by Region (2024-2029) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Deuterated Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Deuterated Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Deuterated Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Deuterated Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Deuterated Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 62. Middle East, Africa, and Latin America Deuterated Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Deuterated Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 64. Teva Company Details
Table 65. Teva Business Overview
Table 66. Teva Deuterated Drugs Product
Table 67. Teva Revenue in Deuterated Drugs Business (2018-2023) & (US$ Million)
Table 68. Teva Recent Developments
Table 69. Suzhou Zelgen Biopharmaceuticals Company Details
Table 70. Suzhou Zelgen Biopharmaceuticals Business Overview
Table 71. Suzhou Zelgen Biopharmaceuticals Deuterated Drugs Product
Table 72. Suzhou Zelgen Biopharmaceuticals Revenue in Deuterated Drugs Business (2018-2023) & (US$ Million)
Table 73. Suzhou Zelgen Biopharmaceuticals Recent Developments
Table 74. Concert Pharmaceuticals Company Details
Table 75. Concert Pharmaceuticals Business Overview
Table 76. Concert Pharmaceuticals Deuterated Drugs Product
Table 77. Concert Pharmaceuticals Revenue in Deuterated Drugs Business (2018-2023) & (US$ Million)
Table 78. Concert Pharmaceuticals Recent Developments
Table 79. Vertex Pharmaceuticals Company Details
Table 80. Vertex Pharmaceuticals Business Overview
Table 81. Vertex Pharmaceuticals Deuterated Drugs Product
Table 82. Vertex Pharmaceuticals Revenue in Deuterated Drugs Business (2018-2023) & (US$ Million)
Table 83. Vertex Pharmaceuticals Recent Developments
Table 84. Hinova Pharma Company Details
Table 85. Hinova Pharma Business Overview
Table 86. Hinova Pharma Deuterated Drugs Product
Table 87. Hinova Pharma Revenue in Deuterated Drugs Business (2018-2023) & (US$ Million)
Table 88. Hinova Pharma Recent Developments
Table 89. Otsuka Pharmaceutical (Avanir) Company Details
Table 90. Otsuka Pharmaceutical (Avanir) Business Overview
Table 91. Otsuka Pharmaceutical (Avanir) Deuterated Drugs Product
Table 92. Otsuka Pharmaceutical (Avanir) Revenue in Deuterated Drugs Business (2018-2023) & (US$ Million)
Table 93. Otsuka Pharmaceutical (Avanir) Recent Developments
Table 94. Poxel SA (DeuteRx) Company Details
Table 95. Poxel SA (DeuteRx) Business Overview
Table 96. Poxel SA (DeuteRx) Deuterated Drugs Product
Table 97. Poxel SA (DeuteRx) Revenue in Deuterated Drugs Business (2018-2023) & (US$ Million)
Table 98. Poxel SA (DeuteRx) Recent Developments
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
Table 1. Global Deuterated Drugs Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Austedo
Table 3. Key Players of Zepsun
Table 4. Key Players of Others
Table 5. Global Deuterated Drugs Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 6. Global Deuterated Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Deuterated Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Deuterated Drugs Market Share by Region (2018-2023)
Table 9. Global Deuterated Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Deuterated Drugs Market Share by Region (2024-2029)
Table 11. Deuterated Drugs Market Trends
Table 12. Deuterated Drugs Market Drivers
Table 13. Deuterated Drugs Market Challenges
Table 14. Deuterated Drugs Market Restraints
Table 15. Global Deuterated Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Deuterated Drugs Revenue Share by Players (2018-2023)
Table 17. Global Top Deuterated Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Deuterated Drugs as of 2022)
Table 18. Global Deuterated Drugs Industry Ranking 2021 VS 2022 VS 2023
Table 19. Global 5 Largest Players Market Share by Deuterated Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 20. Global Key Players of Deuterated Drugs, Headquarters and Area Served
Table 21. Global Key Players of Deuterated Drugs, Product and Application
Table 22. Global Key Players of Deuterated Drugs, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Deuterated Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Deuterated Drugs Revenue Market Share by Type (2018-2023)
Table 26. Global Deuterated Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Deuterated Drugs Revenue Market Share by Type (2024-2029)
Table 28. Global Deuterated Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Deuterated Drugs Revenue Share by Application (2018-2023)
Table 30. Global Deuterated Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Deuterated Drugs Revenue Share by Application (2024-2029)
Table 32. North America Deuterated Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 33. North America Deuterated Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 34. North America Deuterated Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 35. North America Deuterated Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 36. North America Deuterated Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. North America Deuterated Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Deuterated Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 39. Europe Deuterated Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 40. Europe Deuterated Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 41. Europe Deuterated Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 42. Europe Deuterated Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 43. Europe Deuterated Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Europe Deuterated Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 45. Europe Deuterated Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 46. China Deuterated Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 47. China Deuterated Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 48. China Deuterated Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 49. China Deuterated Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 50. Asia Deuterated Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 51. Asia Deuterated Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 52. Asia Deuterated Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 53. Asia Deuterated Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 54. Asia Deuterated Drugs Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 55. Asia Deuterated Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 56. Asia Deuterated Drugs Market Size by Region (2024-2029) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Deuterated Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Deuterated Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Deuterated Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Deuterated Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Deuterated Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 62. Middle East, Africa, and Latin America Deuterated Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Deuterated Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 64. Teva Company Details
Table 65. Teva Business Overview
Table 66. Teva Deuterated Drugs Product
Table 67. Teva Revenue in Deuterated Drugs Business (2018-2023) & (US$ Million)
Table 68. Teva Recent Developments
Table 69. Suzhou Zelgen Biopharmaceuticals Company Details
Table 70. Suzhou Zelgen Biopharmaceuticals Business Overview
Table 71. Suzhou Zelgen Biopharmaceuticals Deuterated Drugs Product
Table 72. Suzhou Zelgen Biopharmaceuticals Revenue in Deuterated Drugs Business (2018-2023) & (US$ Million)
Table 73. Suzhou Zelgen Biopharmaceuticals Recent Developments
Table 74. Concert Pharmaceuticals Company Details
Table 75. Concert Pharmaceuticals Business Overview
Table 76. Concert Pharmaceuticals Deuterated Drugs Product
Table 77. Concert Pharmaceuticals Revenue in Deuterated Drugs Business (2018-2023) & (US$ Million)
Table 78. Concert Pharmaceuticals Recent Developments
Table 79. Vertex Pharmaceuticals Company Details
Table 80. Vertex Pharmaceuticals Business Overview
Table 81. Vertex Pharmaceuticals Deuterated Drugs Product
Table 82. Vertex Pharmaceuticals Revenue in Deuterated Drugs Business (2018-2023) & (US$ Million)
Table 83. Vertex Pharmaceuticals Recent Developments
Table 84. Hinova Pharma Company Details
Table 85. Hinova Pharma Business Overview
Table 86. Hinova Pharma Deuterated Drugs Product
Table 87. Hinova Pharma Revenue in Deuterated Drugs Business (2018-2023) & (US$ Million)
Table 88. Hinova Pharma Recent Developments
Table 89. Otsuka Pharmaceutical (Avanir) Company Details
Table 90. Otsuka Pharmaceutical (Avanir) Business Overview
Table 91. Otsuka Pharmaceutical (Avanir) Deuterated Drugs Product
Table 92. Otsuka Pharmaceutical (Avanir) Revenue in Deuterated Drugs Business (2018-2023) & (US$ Million)
Table 93. Otsuka Pharmaceutical (Avanir) Recent Developments
Table 94. Poxel SA (DeuteRx) Company Details
Table 95. Poxel SA (DeuteRx) Business Overview
Table 96. Poxel SA (DeuteRx) Deuterated Drugs Product
Table 97. Poxel SA (DeuteRx) Revenue in Deuterated Drugs Business (2018-2023) & (US$ Million)
Table 98. Poxel SA (DeuteRx) Recent Developments
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Deuterated Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Deuterated Drugs Market Share by Type: 2022 VS 2029
Figure 3. Austedo Features
Figure 4. Zepsun Features
Figure 5. Others Features
Figure 6. Global Deuterated Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Deuterated Drugs Market Share by Application: 2022 VS 2029
Figure 8. Huntington'S Disease (HD) Case Studies
Figure 9. Tardive Dyskinesia (TD) Case Studies
Figure 10. Cancer Case Studies
Figure 11. Others Case Studies
Figure 12. Deuterated Drugs Report Years Considered
Figure 13. Global Deuterated Drugs Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Deuterated Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Deuterated Drugs Market Share by Region: 2022 VS 2029
Figure 16. Global Deuterated Drugs Market Share by Players in 2022
Figure 17. Global Top Deuterated Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Deuterated Drugs as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Deuterated Drugs Revenue in 2022
Figure 19. North America Deuterated Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Deuterated Drugs Market Share by Type (2018-2029)
Figure 21. North America Deuterated Drugs Market Share by Application (2018-2029)
Figure 22. North America Deuterated Drugs Market Share by Country (2018-2029)
Figure 23. United States Deuterated Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Deuterated Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Deuterated Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 26. Europe Deuterated Drugs Market Share by Type (2018-2029)
Figure 27. Europe Deuterated Drugs Market Share by Application (2018-2029)
Figure 28. Europe Deuterated Drugs Market Share by Country (2018-2029)
Figure 29. Germany Deuterated Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France Deuterated Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. Deuterated Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy Deuterated Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia Deuterated Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries Deuterated Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. China Deuterated Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 36. China Deuterated Drugs Market Share by Type (2018-2029)
Figure 37. China Deuterated Drugs Market Share by Application (2018-2029)
Figure 38. Asia Deuterated Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 39. Asia Deuterated Drugs Market Share by Type (2018-2029)
Figure 40. Asia Deuterated Drugs Market Share by Application (2018-2029)
Figure 41. Asia Deuterated Drugs Market Share by Region (2018-2029)
Figure 42. Japan Deuterated Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. South Korea Deuterated Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. China Taiwan Deuterated Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Southeast Asia Deuterated Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. India Deuterated Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Australia Deuterated Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Deuterated Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Deuterated Drugs Market Share by Type (2018-2029)
Figure 50. Middle East, Africa, and Latin America Deuterated Drugs Market Share by Application (2018-2029)
Figure 51. Middle East, Africa, and Latin America Deuterated Drugs Market Share by Country (2018-2029)
Figure 52. Brazil Deuterated Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Mexico Deuterated Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Turkey Deuterated Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Saudi Arabia Deuterated Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Israel Deuterated Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. GCC Countries Deuterated Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Teva Revenue Growth Rate in Deuterated Drugs Business (2018-2023)
Figure 59. Suzhou Zelgen Biopharmaceuticals Revenue Growth Rate in Deuterated Drugs Business (2018-2023)
Figure 60. Concert Pharmaceuticals Revenue Growth Rate in Deuterated Drugs Business (2018-2023)
Figure 61. Vertex Pharmaceuticals Revenue Growth Rate in Deuterated Drugs Business (2018-2023)
Figure 62. Hinova Pharma Revenue Growth Rate in Deuterated Drugs Business (2018-2023)
Figure 63. Otsuka Pharmaceutical (Avanir) Revenue Growth Rate in Deuterated Drugs Business (2018-2023)
Figure 64. Poxel SA (DeuteRx) Revenue Growth Rate in Deuterated Drugs Business (2018-2023)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Figure 1. Global Deuterated Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Deuterated Drugs Market Share by Type: 2022 VS 2029
Figure 3. Austedo Features
Figure 4. Zepsun Features
Figure 5. Others Features
Figure 6. Global Deuterated Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Deuterated Drugs Market Share by Application: 2022 VS 2029
Figure 8. Huntington'S Disease (HD) Case Studies
Figure 9. Tardive Dyskinesia (TD) Case Studies
Figure 10. Cancer Case Studies
Figure 11. Others Case Studies
Figure 12. Deuterated Drugs Report Years Considered
Figure 13. Global Deuterated Drugs Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Deuterated Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Deuterated Drugs Market Share by Region: 2022 VS 2029
Figure 16. Global Deuterated Drugs Market Share by Players in 2022
Figure 17. Global Top Deuterated Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Deuterated Drugs as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Deuterated Drugs Revenue in 2022
Figure 19. North America Deuterated Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Deuterated Drugs Market Share by Type (2018-2029)
Figure 21. North America Deuterated Drugs Market Share by Application (2018-2029)
Figure 22. North America Deuterated Drugs Market Share by Country (2018-2029)
Figure 23. United States Deuterated Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Deuterated Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Deuterated Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 26. Europe Deuterated Drugs Market Share by Type (2018-2029)
Figure 27. Europe Deuterated Drugs Market Share by Application (2018-2029)
Figure 28. Europe Deuterated Drugs Market Share by Country (2018-2029)
Figure 29. Germany Deuterated Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France Deuterated Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. Deuterated Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy Deuterated Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia Deuterated Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries Deuterated Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. China Deuterated Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 36. China Deuterated Drugs Market Share by Type (2018-2029)
Figure 37. China Deuterated Drugs Market Share by Application (2018-2029)
Figure 38. Asia Deuterated Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 39. Asia Deuterated Drugs Market Share by Type (2018-2029)
Figure 40. Asia Deuterated Drugs Market Share by Application (2018-2029)
Figure 41. Asia Deuterated Drugs Market Share by Region (2018-2029)
Figure 42. Japan Deuterated Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. South Korea Deuterated Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. China Taiwan Deuterated Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Southeast Asia Deuterated Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. India Deuterated Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Australia Deuterated Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Deuterated Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Deuterated Drugs Market Share by Type (2018-2029)
Figure 50. Middle East, Africa, and Latin America Deuterated Drugs Market Share by Application (2018-2029)
Figure 51. Middle East, Africa, and Latin America Deuterated Drugs Market Share by Country (2018-2029)
Figure 52. Brazil Deuterated Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Mexico Deuterated Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Turkey Deuterated Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Saudi Arabia Deuterated Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Israel Deuterated Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. GCC Countries Deuterated Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Teva Revenue Growth Rate in Deuterated Drugs Business (2018-2023)
Figure 59. Suzhou Zelgen Biopharmaceuticals Revenue Growth Rate in Deuterated Drugs Business (2018-2023)
Figure 60. Concert Pharmaceuticals Revenue Growth Rate in Deuterated Drugs Business (2018-2023)
Figure 61. Vertex Pharmaceuticals Revenue Growth Rate in Deuterated Drugs Business (2018-2023)
Figure 62. Hinova Pharma Revenue Growth Rate in Deuterated Drugs Business (2018-2023)
Figure 63. Otsuka Pharmaceutical (Avanir) Revenue Growth Rate in Deuterated Drugs Business (2018-2023)
Figure 64. Poxel SA (DeuteRx) Revenue Growth Rate in Deuterated Drugs Business (2018-2023)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
